Related Experiment Video
Updated: Jun 4, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential
Muqtada Shaikh1, Gaurav Doshi2
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, 400 056, India.
Abstract:
Breast cancer remains a leading global health challenge requiring innovative, therapeutic strategies to improve patient outcomes. This review explores the pivotal roles of non-coding RNAs (ncRNAs), including long non-coding RNA, micro RNA, and circular RNA, in breast cancer biology. We highlight how these molecules regulate critical signaling pathways, influence tumor microenvironments, and contribute to treatment resistance. Our findings underscore the potential of ncRNAs as biomarkers for early diagnosis and as treatment targets for personalized treatment strategies. To pave the way for innovative cancer management approaches, we investigate the complex interactions of ncRNAs and their impact on tumor progression. This comprehensive review enhances our understanding of breast cancer biology while emphasizing the translational significance of ncRNA research in developing effective treatment strategies. Additional research and clinical studies are required to confirm the diagnostic and medicinal value of ncRNAs in breast cancer. Investigating the complex networks of ncRNA interactions and their links to other biological pathways can lead to the discovery of new treatment targets. Furthermore, leveraging advanced technologies, such as machine learning and multi-omics methods, will be critical in improving our understanding of ncRNAs biomarkers and translating these insights into impactful clinical applications.
Insights
Non-coding RNAs (ncRNAs) are key players in breast cancer, influencing tumor growth and treatment resistance. Research highlights their potential as biomarkers for early diagnosis and novel therapeutic targets for personalized medicine.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a major global health concern necessitating novel therapeutic strategies.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in cancer development and progression.
Purpose of the Study:
- To review the multifaceted roles of ncRNAs in breast cancer biology.
- To explore the potential of ncRNAs as diagnostic biomarkers and therapeutic targets.
Main Methods:
- Comprehensive literature review of ncRNAs in breast cancer.
- Analysis of ncRNA involvement in signaling pathways, tumor microenvironment, and treatment resistance.
Main Results:
- ncRNAs, including long non-coding RNA, micro RNA, and circular RNA, significantly regulate breast cancer progression.
- ncRNAs influence tumor microenvironments and contribute to therapeutic resistance.
- ncRNAs show promise as biomarkers for early detection and personalized treatment.
Conclusions:
- ncRNA research offers significant translational value for developing innovative breast cancer management strategies.
- Further research and clinical studies are needed to validate ncRNAs' diagnostic and therapeutic potential.
- Advanced technologies like machine learning and multi-omics are crucial for translating ncRNA insights into clinical applications.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
The Nucleolus
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi

